Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Runt-Related Transcription Factor 1 (RUNX1) (Middle Region) Peptide

RUNX1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5672381

Quick Overview for Runt-Related Transcription Factor 1 (RUNX1) (Middle Region) Peptide (ABIN5672381)

Target

RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))

Origin

Human

Source

  • 9
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    FTNPPQVATY HRAIKITVDG PREPRRHRQK LDDQTKPGSL SFSERLSELE

    Characteristics

    This is a synthetic peptide designed for use in combination with anti- RUNX1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    RUNX1 (Runt-Related Transcription Factor 1 (RUNX1))

    Background

    Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene.

    Alias Symbols: AML1, CBFA2, EVI-1, AMLCR1, PEBP2aB, CBF2alpha, AML1-EVI-1, PEBP2alpha

    Protein Size: 250

    Gene ID

    861

    NCBI Accession

    NM_001001890, NP_001001890
You are here:
Chat with us!